Patients with hepatocellular carcinoma who manifest blood vomiting and vomiting indicate upper gastrointestinal bleeding, which is common when the tumor is combined with esophagogastric fundic varices. Abnormal liver function and coagulation dysfunction may also occur in the late stage of tumor development, which is a manifestation of advanced stage. Survival time varies for each individual, and can be extended to 3-6 months with active and effective symptomatic treatment. Some patients can be controlled by interventional treatment. Patients with hepatocellular carcinoma should actively choose surgery in the early stage, while patients in the middle and late stage should be given nutritional support, hepatoprotection and other symptomatic treatments to regulate the stability of the internal environment according to the needs of the disease, and plasma supplementation, coagulation factors, etc. if necessary. In the later stage, patients are prone to severe bone marrow suppression, so they need to be monitored regularly for changes in relevant laboratory indicators. The incidence of patients with liver malignancy is also very high and is related to dietary structure and family genetic factors.